|
F8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.515730E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.041600E-03 |
| Normal-vs-Stage2 |
3.864400E-01 |
| Normal-vs-Stage3 |
3.66179999999883E-05 |
| Normal-vs-Stage4 |
5.562700E-03 |
| Stage1-vs-Stage2 |
3.983800E-03 |
| Stage1-vs-Stage3 |
5.433500E-02 |
| Stage1-vs-Stage4 |
3.983800E-01 |
| Stage2-vs-Stage3 |
9.76299999999597E-05 |
| Stage2-vs-Stage4 |
4.503000E-03 |
| Stage3-vs-Stage4 |
5.607600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.798760E-04 |
| Normal-vs-AfricanAmerican |
2.329200E-01 |
| Normal-vs-Asian |
5.434400E-04 |
| Caucasian-vs-AfricanAmerican |
5.602200E-01 |
| Caucasian-vs-Asian |
4.685200E-01 |
| AfricanAmerican-vs-Asian |
3.831000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.382620E-01 |
| Normal-vs-Female |
4.429600E-04 |
| Male-vs-Female |
1.041760E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.495290E-03 |
| Normal-vs-Age(41-60Yrs) |
1.847230E-04 |
| Normal-vs-Age(61-80Yrs) |
9.486000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.007600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.551800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.383990E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.174400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.702000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.194600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.997800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.580500E-04 |
| Classical-VS-Follicular |
1.29329999998262E-06 |
| Classical-VS-Other |
5.774000E-01 |
| Classical-VS-Normal |
1.957420E-04 |
| Tall-VS-Follicular |
8.48439984935112E-10 |
| Tall-VS-Other |
3.249800E-01 |
| Tall-VS-Normal |
6.10210000306921E-08 |
| Follicular-VS-Other |
4.004200E-03 |
| Follicular-VS-Normal |
6.460500E-02 |
| Other-VS-Normal |
2.154000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.919900E-02 |
| Normal-vs-N1 |
2.155300E-04 |
| N0-vs-N1 |
2.243700E-02 |
|
|
